Avita Medical Ltd. is a global medical technology company focused on regenerative medicine. The company's patented and proprietary tissue culture, collection and application technology provides innovative treatment solutions derived from a patient's own skin. Avita's lead product, ReCell Spray-On Skin, is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. ReCell is patented, CE-marked for Europe, TGA-registered in Australia and SFDA-cleared in China. FDA trials on the safety and efficacy of ReCell for use in burns and scars are in progress in the U.S.